Drug Shortage Report for TEMODAL
| Report ID | 103683 |
| Drug Identification Number | 02312794 |
| Brand name | TEMODAL |
| Common or Proper name | temozolomide capsules |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TEMOZOLOMIDE |
| Strength(s) | 140MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 5CAP |
| ATC code | L01AX |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-02-07 |
| Actual start date | 2020-02-03 |
| Estimated end date | 2020-02-14 |
| Actual end date | 2020-02-10 |
| Shortage status | Resolved |
| Updated date | 2020-02-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-02-11 | English | Compare |
| v7 | 2020-02-10 | French | Compare |
| v6 | 2020-02-10 | English | Compare |
| v5 | 2020-02-04 | French | Compare |
| v4 | 2020-02-03 | French | Compare |
| v3 | 2020-02-03 | English | Compare |
| v2 | 2020-01-20 | French | Compare |
| v1 | 2020-01-20 | English | Compare |
Showing 1 to 8 of 8